Human papilloma virus vaccines and their role in cancer prevention.
The introduction of the human papilloma virus (HPV) vaccine is the single most important advance in the prevention of cervical cancer since the introduction of cervical cytology half a century ago. Vaccination should ideally occur prior to a female's first sexual experience. This article suggests that the HPV vaccine should be publicly funded in New Zealand.
Jones
Ronald W
RW
Gynaecological Oncology Service, National Women's Hospital, Private Bag 92 189, Auckland. MBarrios@adhb.govt.nz
Coughlan
Edward P
EP
Reid
J Stewart
JS
Sykes
Peter
P
Watson
Peter D
PD
Cook
Catherine
C
D015984:Causality; D015897:Comorbidity; D003218:Condylomata Acuminata / Q000453:epidemiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000639:trends; D015994:Incidence; D008297:Male; D009520:New Zealand / Q000453:epidemiology; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D015995:Prevalence; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000517:prevention & control*
D053918:Papillomavirus Vaccines